Nasdaq Down 50 Points; US Trade Deficit Widens In July
Portfolio Pulse from Lisa Levin
US stocks traded lower with the Nasdaq Composite falling around 50 points. The US trade deficit widened to $65 billion in July. Palisade Bio, FOXO Technologies, and iCoreConnect saw their shares rise due to various positive developments. EZGO Technologies, Verb Technology Company, and Overstock.com saw their shares drop due to negative news.
September 06, 2023 | 1:59 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
EZGO Technologies shares dropped 70% after the company reported pricing of $10 million registered direct offering.
The pricing of a $10 million registered direct offering is a negative development for EZGO Technologies, leading to a drop in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Overstock.com shares fell 23% after issuing an update on its third-quarter performance.
The update on its third-quarter performance is a negative development for Overstock.com, leading to a drop in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Verb Technology Company shares dropped 32% despite the launch of a technology integration and strategic relationship with TikTok.
Despite the positive news of a partnership with TikTok, Verb Technology Company's shares dropped, indicating other factors at play.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
FOXO Technologies shares rose 49% after its subsidiary announced an agreement with Atrio.
The agreement with Atrio is a positive development for FOXO Technologies, leading to a rise in its share price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
iCoreConnect shares rose 43% after announcing a new version of its encrypted HIPAA email and referral network.
The announcement of a new product version is a positive development for iCoreConnect, leading to a rise in its share price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Palisade Bio shares rose 131% due to an exclusive worldwide licensing agreement with Giiant Pharma.
The licensing agreement with Giiant Pharma is a positive development for Palisade Bio, leading to a rise in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100